Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)
China · Delayed Price · Currency is CNY 17.81
-0.52 (-2.84%)
Sep 4, 2026, 3:04 PM CST
SHE:300562 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,893 | 2,902 | 3,223 | 2,475 | 2,439 | 3,516 | |
Market Cap Growth | 20.44% | -9.96% | 30.22% | 1.47% | -30.63% | -15.21% |
Enterprise Value | 3,196 | 2,266 | 2,670 | 1,942 | 1,972 | 3,083 |
Last Close Price | 17.81 | 13.21 | 14.47 | 10.79 | 10.73 | 15.54 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 39.01 | 35.39 | 52.52 | 72.01 | - | 396.45 |
Forward PE | - | 43.47 | 43.77 | 48.55 | 14.54 | 23.53 |
PS Ratio | 3.90 | 2.94 | 3.28 | 2.80 | 2.29 | 1.93 |
PB Ratio | 3.53 | 2.89 | 3.30 | 2.42 | 2.44 | 3.36 |
P/TBV Ratio | 3.63 | 3.00 | 3.49 | 2.59 | 2.66 | 3.65 |
P/FCF Ratio | 25.29 | 20.97 | 35.47 | 40.41 | 38.34 | - |
P/OCF Ratio | 23.43 | 18.98 | 27.12 | 33.38 | 28.81 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.20 | 2.30 | 2.71 | 2.20 | 1.85 | 1.69 |
EV/EBITDA Ratio | 21.93 | 19.78 | 36.33 | 50.99 | - | 168.01 |
EV/EBIT Ratio | 26.13 | 23.72 | 51.96 | 136.60 | - | 34484.58 |
EV/FCF Ratio | 20.76 | 16.38 | 29.39 | 31.70 | 31.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.06 | 0.05 | 0.19 | 0.13 | 0.14 | 0.04 |
Debt / EBITDA Ratio | 0.44 | 0.43 | 2.43 | 3.13 | - | 1.54 |
Debt / FCF Ratio | 0.42 | 0.37 | 2.09 | 2.20 | 2.27 | - |
Net Debt / Equity Ratio | -0.61 | -0.65 | -0.59 | -0.53 | -0.51 | -0.48 |
Net Debt / EBITDA Ratio | -4.78 | -5.72 | -7.81 | -14.25 | 12.52 | -27.19 |
Net Debt / FCF Ratio | -4.38 | -4.74 | -6.32 | -8.86 | -8.03 | 7.27 |
Asset Turnover | 0.67 | 0.68 | 0.64 | 0.57 | 0.64 | 1.15 |
Inventory Turnover | 8.18 | 7.40 | 7.07 | 6.13 | 5.28 | 6.83 |
Quick Ratio | 2.61 | 2.37 | 1.80 | 1.84 | 1.70 | 1.33 |
Current Ratio | 2.90 | 2.62 | 2.03 | 2.04 | 1.97 | 1.67 |
Return on Equity (ROE) | 9.40% | 8.11% | 5.81% | 3.08% | -3.73% | -0.03% |
Return on Assets (ROA) | 5.15% | 4.11% | 2.09% | 0.57% | -2.42% | 0.00% |
Return on Invested Capital (ROIC) | 29.66% | 24.25% | 11.27% | 2.76% | -12.49% | 0.02% |
Return on Capital Employed (ROCE) | 10.70% | 9.40% | 5.20% | 1.30% | -6.20% | 0.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 2.56% | 2.83% | 1.90% | 1.39% | -1.33% | 0.25% |
FCF Yield | 3.95% | 4.77% | 2.82% | 2.48% | 2.61% | -1.95% |
Dividend Yield | 1.46% | 1.97% | 1.93% | 1.39% | 0.09% | 0.06% |
Payout Ratio | 58.18% | 77.18% | 106.26% | 16.42% | - | 503.75% |
Buyback Yield / Dilution | -0.53% | -0.36% | -0.87% | 0.24% | 2.70% | -16.93% |
Total Shareholder Return | 0.93% | 1.61% | 1.07% | 1.63% | 2.80% | -16.86% |